Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The underlying molecular mechanisms and biomarkers of plaque vulnerability based on bioinformatics analysis. | Eur J Med Res | 2022 | 36303246 | PubTator, text mining | PubMed |
| Mutation Analysis of Thin Basement Membrane Nephropathy. | Genes (Basel) | 2022 | 36292665 | PubTator, text mining | PubMed |
| Genomic Predictors of Brisk Walking Are Associated with Elite Sprinter Status. | Genes (Basel) | 2022 | 36292594 | PubTator, text mining | PubMed |
| Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends. | Cancers (Basel) | 2022 | 36291803 | PubTator, text mining | PubMed |
| CiberAMP: An R Package to Identify Differential mRNA Expression Linked to Somatic Copy Number Variations in Cancer Datasets. | Biology (Basel) | 2022 | 36290315 | PubTator, text mining | PubMed |
| Noncoding RNAs and Virus and Treatment in Allergic Rhinitis. | Evid Based Complement Alternat Med | 2022 | 36285160 | PubTator, text mining | PubMed |
| Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative state. | Theranostics | 2022 | 36276637 | PubTator, text mining | PubMed |
| The expression profiles of circular RNAs and competing endogenous RNA networks in intrahepatic cholangiocarcinoma. | Front Cell Dev Biol | 2022 | 36274844 | PubTator, text mining | PubMed |
| LncRNA SPINT1-AS1/miR-433-3p/E2F3 positive feedback loop promotes the KRAS-mutant colorectal cancer cell proliferation, migration and invasion. | Pathol Res Pract | 2022 | 36274378 | PubTator, text mining | PubMed |
| A review on the role of cyclin dependent kinases in cancers. | Cancer Cell Int | 2022 | 36266723 | PubTator, text mining | PubMed |
| Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 Axis. | Int J Biol Sci | 2022 | 36263172 | PubTator, text mining | PubMed |
| Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression. | Asian J Androl | 2022 | 36254891 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. | Adv Sci (Weinh) | 2022 | 36253096 | PubTator, text mining | PubMed |
| LncRNA NEAT1 regulates the growth, migration, and invasion of the human esophageal cancer cells via the miR-377/E2F3 axis. | Acta Biochim Pol | 2022 | 36252156 | PubTator, text mining | PubMed |
| The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers. | Front Genet | 2022 | 36246634 | PubTator, text mining | PubMed |
| Mechanism underlying circRNA dysregulation in the TME of digestive system cancer. | Front Immunol | 2022 | 36238299 | PubTator, text mining | PubMed |
Fermentation Extract of Naringenin Increases the Expression of Estrogenic Receptor β and Modulates Genes Related to the p53 Signalling Pathway, miR-200c and miR-141 in Human Colon Cancer Cells Exposed to BPA. | Molecules | 2022 | 36235125 | PubTator, text mining | PubMed |
| miRNA: A Promising Therapeutic Target in Cancer. | Int J Mol Sci | 2022 | 36232799 | PubTator, text mining | PubMed |
| Subpathway Analysis of Transcriptome Profiles Reveals New Molecular Mechanisms of Acquired Chemotherapy Resistance in Breast Cancer. | Cancers (Basel) | 2022 | 36230801 | PubTator, text mining | PubMed |
| A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer. | Cancers (Basel) | 2022 | 36230649 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=26